Lp(a): a basic clinical approach with Dr. Steven Nissen Part 1 of 2

Dr. Steven Nissen, the Chief Academic Officer at the Cleveland Clinic and a leading expert in cardiology, joins Dr. Thomas Nero to discuss the critical role of lipoprotein(a) in cardiovascular disease. They emphasize the necessity of routine testing for Lp(a), particularly for those with family histories of heart disease. The conversation includes challenges in lowering Lp(a) levels, the limitations of current treatments, and insights into ongoing clinical trials for drugs like pellicarsin. Real patient scenarios highlight aggressive strategies for managing elevated LDL post-myocardial infarction.